Articles related to CORONARY ARTERY DISEASE (CAD)

The study identifies three scenarios where CAC testing provides limited value: “too early” (younger patients without risk factors), “too late” (elderly patients or those already on statins), and “too often” (repeated imaging after statin initiation).

A network meta-analysis of 24 trials (16,371 patients) found complete revascularization in myocardial infarction with multivessel disease reduced all-cause mortality by 15% compared to culprit-only revascularization, suggesting potential improved outcomes for this population.

With stress tests potentially costing the US healthcare system up to $500 million annually and leading to unwarranted procedures, it’s time to reassess their routine use in asymptomatic patients and consider more accurate diagnostic alternatives.

Leveraging artificial intelligence, the CathEF algorithm offers a groundbreaking method to assess heart function directly from angiogram videos, potentially reducing the need for invasive diagnostics and enhancing patient care strategies.

This study provides valuable insights into the comparative benefits and risks of rosuvastatin and atorvastatin in adults with coronary artery disease. Notably, while both drugs showed comparable efficacy, rosuvastatin was associated with a higher risk of new onset diabetes mellitus and cataract surgery.